Tapering of inhaled corticosteroid (ICS) treatment

DRUG2 trials

Sponsors

Hvidovre University Hospital, Franciscus Gasthuis

Conditions

AsthmaSevere Asthma

Phase 4

Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma

CompletedNCT03141424

Hvidovre University HospitalAsthma

Start: 2022-06-01End: 2024-10-25Updated: 2025-03-17

Unknown Phase

Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes

Enrolling by invitationNCT07713498

Franciscus GasthuisSevere Asthma

Start: 2026-05-01End: 2027-10-01Target: 61Updated: 2026-07-21

Related Papers

Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype - a randomized controlled trial study protocol.

2023-10-044 citations